Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $15.0600 (-0.66%) ($15.0600 - $15.0600) on Tue. Feb. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.53% (three month average) | RSI | 30 | Latest Price | $15.0600(-0.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(64%) IBUY(62%) IWC(62%) IWM(61%) | Factors Impacting EDIT price | EDIT will decline at least -2.265% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-11%) TBT(-10%) EDOC(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.265% (StdDev 4.53%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.93(-87.18%) | Resistance Level | $17.33 | 5 Day Moving Average | $15.83(-4.86%) | 10 Day Moving Average | $16.37(-8%) | 20 Day Moving Average | $17.33(-13.1%) | To recent high | -55.7% | To recent low | 0% | Market Cap | $935m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |